Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. The Extracellular Matrix Glycoprotein Tenascin-C Is Beneficial for Spinal Cord Regeneration

The Extracellular Matrix Glycoprotein Tenascin-C Is Beneficial for Spinal Cord Regeneration

Molecular Therapy, 2010 · DOI: 10.1038/mt.2010.133 · Published: October 1, 2010

Spinal Cord InjuryRegenerative MedicineNeurology

Simple Explanation

This study investigates the role of Tenascin-C (TNC), a component of the extracellular matrix, in spinal cord injury recovery. The research compares recovery in TNC-deficient mice (TNC–/–) versus wild-type mice (TNC+/+) after spinal cord injury. The study found that TNC-deficient mice showed impaired locomotor recovery compared to wild-type mice, indicating TNC's importance in the recovery process. The impaired recovery was associated with reduced nerve excitability and reduced sprouting of certain nerve fibers. Introducing a specific component of TNC (fnD) through viral delivery improved locomotor recovery in wild-type mice. This suggests that TNC and its components have the potential to be used as a therapeutic approach for spinal cord injury.

Study Duration
12 weeks
Participants
TNC–/– and TNC+/+ mice
Evidence Level
Not specified

Key Findings

  • 1
    TNC-deficient mice exhibit impaired locomotor recovery after spinal cord injury compared to wild-type mice.
  • 2
    Impaired recovery in TNC-deficient mice is associated with attenuated excitability of the plantar Hoffmann reflex and reduced glutamatergic input.
  • 3
    Overexpression of TNC-fnD via adeno-associated virus in wild-type mice improved locomotor recovery and increased monaminergic axons sprouting.

Research Summary

The study investigates the role of tenascin-C (TNC) in spinal cord regeneration using TNC-deficient mice and wild-type controls after spinal cord injury. The findings indicate that TNC deficiency impairs locomotor recovery. Further analysis revealed that TNC deficiency leads to reduced nerve excitability, decreased glutamatergic input, and enhanced degeneration of corticospinal axons. Delivery of TNC-fnD via viral vectors in wild-type mice improved locomotor recovery, increased nerve sprouting, and reduced lesion scar volume, suggesting a potential therapeutic approach for spinal cord injury.

Practical Implications

Therapeutic Target

TNC and its domains, particularly fnD, represent potential therapeutic targets for promoting regeneration after spinal cord injury.

Viral Vector Delivery

Adeno-associated virus (AAV) vectors can be used to effectively deliver TNC-fnD to the injured spinal cord, enhancing recovery.

Combination Therapies

Combining TNC-based treatments with other regenerative molecules and agents may further improve outcomes after spinal cord injury.

Study Limitations

  • 1
    The mechanisms regulating TNC expression in the injured spinal cord are not fully understood.
  • 2
    The study primarily focuses on the effects of TNC on axonal survival and sprouting, with less emphasis on other potential mechanisms.
  • 3
    The long-term effects and potential side effects of viral-mediated TNC delivery were not extensively investigated.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury